HomeJANX • NASDAQ
add
Janux Therapeutics Inc
Previous close
$24.76
Day range
$25.01 - $26.88
Year range
$22.48 - $71.71
Market cap
1.55B USD
Avg Volume
1.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.84M | 34.03% |
Net income | -23.51M | -59.27% |
Net profit margin | — | — |
Earnings per share | -0.38 | -26.67% |
EBITDA | -34.38M | -75.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.01B | 55.60% |
Total assets | 1.05B | 52.51% |
Total liabilities | 38.30M | 15.30% |
Total equity | 1.01B | — |
Shares outstanding | 59.18M | — |
Price to book | 1.45 | — |
Return on assets | -8.26% | — |
Return on capital | -8.38% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -23.51M | -59.27% |
Cash from operations | -17.02M | -14.74% |
Cash from investing | -340.39M | -199.28% |
Cash from financing | 554.00K | -99.83% |
Net change in cash | -356.86M | -284.33% |
Free cash flow | -11.68M | -8.04% |
About
Founded
2017
Website
Employees
91
